M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by

Steven J Werden1, John W Barrett, Gen Wang

  • 1Department of Microbiology and Immunology, University of Western Ontario and Robarts Research Institute, London, Ontario, Canada.

Journal of Virology
|December 8, 2006
PubMed

Insights

Myxoma virus M-T5 protein activates Akt, enabling cancer cell infection. The host protein PIKE-A can substitute for M-T5, rescuing viral replication in resistant cancer cells. This highlights Akt activation

Area of Science:

  • Virology
  • Molecular Biology
  • Oncology

Background:

  • Myxoma virus (MV) host range factor M-T5 activates cellular Akt, facilitating MV replication in human cancer cells.
  • Cancer cell susceptibility to MV infection correlates with Akt phosphorylation levels.
  • MV lacking M-T5 (vMyxT5KO) fails to infect certain cancer cells lacking endogenous phosphorylated Akt.

Purpose of the Study:

  • To investigate the role of the host protein PIKE-A as a functional counterpart to MV M-T5.
  • To determine if PIKE-A can restore MV permissiveness in resistant cancer cells.

Main Methods:

  • Sequence similarity analysis identified PIKE-A as a potential Akt-binding protein.
  • Transfection of PIKE-A into cancer cell lines.
  • Infection assays with wild-type MV and vMyxT5KO in transfected and non-transfected cells.

Main Results:

  • Transfected PIKE-A rescued vMyxT5KO replication in previously resistant type II human cancer cells.
  • Ectopic PIKE-A expression rendered nonpermissive type III cancer cells fully permissive to MV infection.
  • PIKE-A activates Akt kinase activity in a GTP-dependent manner and promotes cancer cell invasiveness.

Conclusions:

  • The MV M-T5 protein is functionally interchangeable with the host PIKE-A protein.
  • Activation of host Akt by either M-T5 or PIKE-A is critical for human cancer cell permissiveness to MV.
  • This interaction provides a mechanism for targeting cancer cells with oncolytic viruses.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Actin Polymerization and Cell Motility01:13

Actin Polymerization and Cell Motility

Actin is a family of globular proteins that are highly abundant in eukaryotic cells. It makes up approximately 1-5% of total cell protein concentration. Actin monomers polymerize to form a complex network of polarized filaments, the actin cytoskeleton, that plays a crucial role in many cellular processes, including cell motility, division, endocytosis, and metastasis of cancer cells.
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...